Estrogen receptor beta expression correlates with proliferation in desmoid tumors.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 28 01 2019
accepted: 31 01 2019
pubmed: 12 2 2019
medline: 15 5 2019
entrez: 12 2 2019
Statut: ppublish

Résumé

Estrogen receptor signaling and cyclin D1 have a major role in tumor cell proliferation in breast cancer. Desmoid tumors are rare neoplasms that may respond to endocrine treatment. The present study aimed to investigate the expression levels and the clinical relevance of estrogen receptor beta (ERβ) and cyclin D1 in desmoid tumors. This study consists of 83 patients with a surgically treated desmoid tumor. ERβ and cyclin D1 expression was examined by immunohistochemistry in tissue microarrays. Cyclin A and Ki67 were studied in our previous work. Median ERβ expression was 10.8%. ERβ expression correlated with expression of the proliferation antigens Ki67 (r ERβ and cyclin D1 immunopositivity correlated with high proliferation in desmoid tumors. High ERβ expression might be predictive for postoperative recurrence.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Estrogen receptor signaling and cyclin D1 have a major role in tumor cell proliferation in breast cancer. Desmoid tumors are rare neoplasms that may respond to endocrine treatment. The present study aimed to investigate the expression levels and the clinical relevance of estrogen receptor beta (ERβ) and cyclin D1 in desmoid tumors.
METHODS METHODS
This study consists of 83 patients with a surgically treated desmoid tumor. ERβ and cyclin D1 expression was examined by immunohistochemistry in tissue microarrays. Cyclin A and Ki67 were studied in our previous work.
RESULTS RESULTS
Median ERβ expression was 10.8%. ERβ expression correlated with expression of the proliferation antigens Ki67 (r
CONCLUSIONS CONCLUSIONS
ERβ and cyclin D1 immunopositivity correlated with high proliferation in desmoid tumors. High ERβ expression might be predictive for postoperative recurrence.

Identifiants

pubmed: 30742303
doi: 10.1002/jso.25407
doi:

Substances chimiques

Biomarkers, Tumor 0
CCND1 protein, human 0
ESR2 protein, human 0
Estrogen Receptor beta 0
Cyclin D1 136601-57-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

873-879

Subventions

Organisme : Sigrid Juséliuksen Säätiö
Organisme : Finska Läkaresällskapet
Organisme : Medicinska Understödsföreningen Liv och Hälsa
Organisme : Helsinki University Hospital Research funds

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Kirsi Santti (K)

Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Hanna Ihalainen (H)

Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Plastic Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Mikko Rönty (M)

Department of Pathology, HUSLAB and University of Helsinki, Helsinki, Finland.

Christina Karlsson (C)

Department of Medical Diagnostics, School of Health Sciences, Örebro University, Örebro, Sweden.

Caj Haglund (C)

Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Translational Cancer Biology, Reseach Programs Unit, University of Helsinki, Helsinki, Finland.

Mika Sampo (M)

Department of Pathology, HUSLAB and University of Helsinki, Helsinki, Finland.

Maija Tarkkanen (M)

Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Carl Blomqvist (C)

Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Oncology, Örebro University Hospital, Örebro, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH